ADPT
Price
$12.36
Change
-$0.69 (-5.29%)
Updated
Aug 18, 04:55 PM (EDT)
Capitalization
1.99B
73 days until earnings call
ARRY
Price
$8.43
Change
+$0.81 (+10.63%)
Updated
Aug 18, 04:59 PM (EDT)
Capitalization
1.16B
80 days until earnings call
Interact to see
Advertisement

ADPT vs ARRY

Header iconADPT vs ARRY Comparison
Open Charts ADPT vs ARRYBanner chart's image
Adaptive Biotechnologies
Price$12.36
Change-$0.69 (-5.29%)
Volume$8.21K
Capitalization1.99B
Array Technologies
Price$8.43
Change+$0.81 (+10.63%)
Volume$166.25K
Capitalization1.16B
ADPT vs ARRY Comparison Chart in %
Loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADPT vs. ARRY commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a Hold and ARRY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (ADPT: $13.04 vs. ARRY: $7.62)
Brand notoriety: ADPT: Notable vs. ARRY: Not notable
ADPT represents the Biotechnology, while ARRY is part of the Alternative Power Generation industry
Current volume relative to the 65-day Moving Average: ADPT: 86% vs. ARRY: 276%
Market capitalization -- ADPT: $1.99B vs. ARRY: $1.16B
ADPT [@Biotechnology] is valued at $1.99B. ARRY’s [@Alternative Power Generation] market capitalization is $1.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The market cap for tickers in the [@Alternative Power Generation] industry ranges from $118.24B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B. The average market capitalization across the [@Alternative Power Generation] industry is $1.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 0 FA rating(s) are green whileARRY’s FA Score has 1 green FA rating(s).

  • ADPT’s FA Score: 0 green, 5 red.
  • ARRY’s FA Score: 1 green, 4 red.
According to our system of comparison, ARRY is a better buy in the long-term than ADPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 5 TA indicator(s) are bullish while ARRY’s TA Score has 5 bullish TA indicator(s).

  • ADPT’s TA Score: 5 bullish, 5 bearish.
  • ARRY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ADPT and ARRY are a good buy in the short-term.

Price Growth

ADPT (@Biotechnology) experienced а +6.89% price change this week, while ARRY (@Alternative Power Generation) price change was +38.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.83%. For the same industry, the average monthly price growth was +22.69%, and the average quarterly price growth was +23.25%.

The average weekly price growth across all stocks in the @Alternative Power Generation industry was +11.15%. For the same industry, the average monthly price growth was +3.38%, and the average quarterly price growth was +28.37%.

Reported Earning Dates

ADPT is expected to report earnings on Oct 30, 2025.

ARRY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+8.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Alternative Power Generation (+11.15% weekly)

The alternative power generation industry consists of companies that operate power facilities converting non-conventional forms of energy into electricity. These energy forms are alternatives to fossil fuels, and many of them are derived from natural resources. Alternative energy forms include solar, wind, hydro, and geothermal steam. A major purpose behind using alternative energy – also called ‘clean’ energy - is to address concerns related to the more conventional fossil fuels, such as the latter’s high carbon dioxide emissions which is often considered a factor in global warming. Alternative power generation has been gaining traction in recent years, and could grow further in the future. Large organizations like Google have invested substantially in wind and solar energy-powered electricity. Some of the prominent U.S. companies operating in the alternative power generation industry includes Ormat Technologies, Inc., TerraForm Power, Inc. and NextEra Energy Partners LP.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADPT($1.99B) has a higher market cap than ARRY($1.16B). ADPT YTD gains are higher at: 117.515 vs. ARRY (26.159). ADPT has higher annual earnings (EBITDA): -111.63M vs. ARRY (-148.26M). ARRY has more cash in the bank: 348M vs. ADPT (193M). ADPT has less debt than ARRY: ADPT (86.9M) vs ARRY (679M). ARRY has higher revenues than ADPT: ARRY (1.07B) vs ADPT (190M).
ADPTARRYADPT / ARRY
Capitalization1.99B1.16B171%
EBITDA-111.63M-148.26M75%
Gain YTD117.51526.159449%
P/E RatioN/A56.91-
Revenue190M1.07B18%
Total Cash193M348M55%
Total Debt86.9M679M13%
FUNDAMENTALS RATINGS
ADPT vs ARRY: Fundamental Ratings
ADPT
ARRY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
93
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
3649
P/E GROWTH RATING
1..100
10028
SEASONALITY SCORE
1..100
8n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADPT's Valuation (63) in the Hospital Or Nursing Management industry is in the same range as ARRY (93) in the Biotechnology industry. This means that ADPT’s stock grew similarly to ARRY’s over the last 12 months.

ADPT's Profit vs Risk Rating (100) in the Hospital Or Nursing Management industry is in the same range as ARRY (100) in the Biotechnology industry. This means that ADPT’s stock grew similarly to ARRY’s over the last 12 months.

ADPT's SMR Rating (97) in the Hospital Or Nursing Management industry is in the same range as ARRY (100) in the Biotechnology industry. This means that ADPT’s stock grew similarly to ARRY’s over the last 12 months.

ADPT's Price Growth Rating (36) in the Hospital Or Nursing Management industry is in the same range as ARRY (49) in the Biotechnology industry. This means that ADPT’s stock grew similarly to ARRY’s over the last 12 months.

ARRY's P/E Growth Rating (28) in the Biotechnology industry is significantly better than the same rating for ADPT (100) in the Hospital Or Nursing Management industry. This means that ARRY’s stock grew significantly faster than ADPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADPTARRY
RSI
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
75%
Momentum
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EQPGX25.71-0.07
-0.27%
Fidelity Advisor Equity Growth I
IEDZX13.73-0.05
-0.36%
Voya Large Cap Value R6
NBRAX26.38-0.11
-0.42%
Neuberger Berman M/C Intrinsic Val A
TSFCX12.53-0.11
-0.87%
Touchstone Small Cap C
FMIUX38.85-0.48
-1.22%
FMI Common Stock Institutional